The North America Metagenomics Market should witness market growth of 13.0% CAGR during the forecast period (2022-2028).
Shotgun sequencing identifies genes present in environmental materials. In the past, clone libraries were utilized to facilitate sequencing. With the development of high throughput sequencing technology, however, the cloning step is no longer required, and larger sequencing data yields can be produced without this labor-intensive bottleneck. Shotgun metagenomics gives information on both the species in the community and feasible metabolic processes.
Because the collecting of DNA from an environment is essentially uncontrolled, the most abundant microorganisms in an environmental sample are disproportionately represented in the sequence data that results. Prohibitively large sample sizes are required to attain the high coverage required to properly resolve the genomes of underrepresented community members.
On the other hand, the random nature of shotgun sequencing ensures that many of these species, which would otherwise go undiscovered using conventional culturing procedures, will be represented by at least tiny sequence segments. High throughput sequencing does not require DNA cloning before sequencing, therefore eliminating one of the major biases and bottlenecks in environmental sampling. Massive parallel 454 pyrosequencing was utilized for the first high-throughput metagenomic research.
The majority of these funds would be allocated to the three top causes of death: cancer, cardiovascular, and respiratory conditions. In Canada's hybrid public-private healthcare system, the government pays for services while the private sector provides them. In Canada, each province and territory are responsible for its healthcare system. Consequently, each province had a unique system for organizing, administering, and procuring healthcare. In Canada, hospitals and other healthcare institutions have several buying alternatives, including going it alone, utilizing group purchasing organizations (GPOs), and utilizing shared services organizations (SSOs).
The US market dominated the North America Metagenomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,053.3 Million by 2028.The Canada market is poised to grow at a CAGR of 15.6% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 14.6% during (2022-2028).
Based on Workflow, the market is segmented into Sequencing, Pre-sequencing and Data Analysis. Based on Product, the market is segmented into Kits & Reagents, Sequencing & Data Analytics Services and Software. Based on Technology, the market is segmented into Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing and Others. Based on Application, the market is segmented into Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Nutrition and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and F. Hoffmann-La Roche Ltd.
Shotgun sequencing identifies genes present in environmental materials. In the past, clone libraries were utilized to facilitate sequencing. With the development of high throughput sequencing technology, however, the cloning step is no longer required, and larger sequencing data yields can be produced without this labor-intensive bottleneck. Shotgun metagenomics gives information on both the species in the community and feasible metabolic processes.
Because the collecting of DNA from an environment is essentially uncontrolled, the most abundant microorganisms in an environmental sample are disproportionately represented in the sequence data that results. Prohibitively large sample sizes are required to attain the high coverage required to properly resolve the genomes of underrepresented community members.
On the other hand, the random nature of shotgun sequencing ensures that many of these species, which would otherwise go undiscovered using conventional culturing procedures, will be represented by at least tiny sequence segments. High throughput sequencing does not require DNA cloning before sequencing, therefore eliminating one of the major biases and bottlenecks in environmental sampling. Massive parallel 454 pyrosequencing was utilized for the first high-throughput metagenomic research.
The majority of these funds would be allocated to the three top causes of death: cancer, cardiovascular, and respiratory conditions. In Canada's hybrid public-private healthcare system, the government pays for services while the private sector provides them. In Canada, each province and territory are responsible for its healthcare system. Consequently, each province had a unique system for organizing, administering, and procuring healthcare. In Canada, hospitals and other healthcare institutions have several buying alternatives, including going it alone, utilizing group purchasing organizations (GPOs), and utilizing shared services organizations (SSOs).
The US market dominated the North America Metagenomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,053.3 Million by 2028.The Canada market is poised to grow at a CAGR of 15.6% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 14.6% during (2022-2028).
Based on Workflow, the market is segmented into Sequencing, Pre-sequencing and Data Analysis. Based on Product, the market is segmented into Kits & Reagents, Sequencing & Data Analytics Services and Software. Based on Technology, the market is segmented into Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing and Others. Based on Application, the market is segmented into Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Nutrition and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and F. Hoffmann-La Roche Ltd.
Scope of the Study
By Workflow
- Sequencing
- Pre-sequencing
- Data Analysis
By Product
- Kits & Reagents
- Sequencing & Data Analytics Services
- Software
By Technology
- Shotgun Sequencing
- 16S Sequencing
- Whole Genome Sequencing
- Others
By Application
- Environmental
- Clinical Diagnostics
- Drug Discovery
- Biotechnology
- Food & Nutrition
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Novogene Co., Ltd.
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc. (Takara Holdings Inc.)
- Oxford Expression Technologies Ltd.
- F. Hoffmann-La Roche Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Metagenomics Market by Workflow
Chapter 5. North America Metagenomics Market by Product
Chapter 6. North America Metagenomics Market by Technology
Chapter 7. North America Metagenomics Market by Application
Chapter 8. North America Metagenomics Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Novogene Co., Ltd.
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc. (Takara Holdings Inc.)
- Oxford Expression Technologies Ltd.
- F. Hoffmann-La Roche Ltd.
Methodology
LOADING...
